Moderna Inc. buy UBS Group AG
Start price
21.11.25
/
50%
€20.58
Target price
21.11.26
-
Performance (%)
33.09%
Price
23.12.25
€27.39
Summary
This prediction is currently active. With a performance of 33.09% the BUY prediction by UBS_Group_AG is a big success. This prediction currently runs until 21.11.26. The prediction end date can be changed by UBS_Group_AG at any time. UBS_Group_AG has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Moderna Inc. | -5.044% | -5.044% |
| iShares Core DAX® | 0.224% | 2.457% |
| iShares Nasdaq 100 | 0.371% | -0.320% |
| iShares Nikkei 225® | 0.972% | -0.829% |
| iShares S&P 500 | 0.417% | -0.157% |
Comments by UBS_Group_AG for this prediction
In the thread Moderna Inc. diskutieren
Moderna (NASDAQ:MRNA) had its "buy" rating reaffirmed by analysts at UBS Group AG.
Ratings data for MRNA provided by MarketBeat